Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/10/2018
SIETES contiene 92571 citas

 
 
 1 a 20 de 620 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Qato DM, Ozenberger K, Olfson M. Prevalence of prescription medications with depression as a potential adverse effect among adults in the United States. JAMA 2018;319:12 de junio. [Ref.ID 102780]
2.Enlace a cita original Cita con resumen
Malhotra K, Katsanos AH, Bilal M, Ishfaq MF, Goyal N, Tsivgoulis G. Cerebrovascular outcomes with proton pump inhibitors and thienopyridines. Stroke 2018;49:febrero. [Ref.ID 102619]
3. Cita con resumen
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]
4. Cita con resumen
Torvinen-Kiskinen S, Tolppanen A-M, Koponen M, Tanskanen A, Tihonen J, Hartikainen S, Taipale H. Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease—a nested case-control study. Aliment Pharmacol Ther 2018;47:1135-42. [Ref.ID 102491]
5. Cita con resumen
Anónimo. Maladies auto-immunes d'origine médicamenteuse. Prescrire 2017;37:346-53. [Ref.ID 101654]
6. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
7. Cita con resumen
Jensen AK, Simonsen JE, Ethelberg S. Use of proton pump inhibitors and the risk of listeriosis: a nationwide registry-based case-control study. Clin Infect Dis 2017;64:845-51. [Ref.ID 101519]
8. Cita con resumen
Huizinga P, Kluytmans-van den Bergh M, van Rijen M, Willemsen I, van't Veer N, Kluytmans J. Proton pump inhibitor use is associated with extended-spectrum ß-lactamase-producing enterobacteriaceae rectal carriage at hospital admission: a cross-sectional study. Clin Infect Dis 2017;64:361-3. [Ref.ID 101508]
9. Cita con resumen
Huizinga P, Kluytmans– van den Bergh M, Willemsen I, van ‘t Veer N, Kluytmans J. Proton pump inhibitor use is associated with extended-spectrum ß-lactamase–producing Enterobacteriaceae rectal carriage at hospital admission: a cross-sectional study . Clin Infect Dis 2016;64:361-3. [Ref.ID 101382]
10. Cita con resumen
Jensen AK, Simonsen J, Ethelberg S. Use of proton pump inhibitors and the risk of listeriosis. A nationwide registry-based case-control study. Clin Infect Dis 2017;64:845-51. [Ref.ID 101381]
11. Cita con resumen
Gisbert JP, Molina-Infante J. Tratamiento actual de la infección por Helicobacter pylori. Med Clin (Barc) 2017;148:20-2. [Ref.ID 101339]
12. Cita con resumen
Anónimo. Diarrhées d'origine médicamenteuse. Prescrire 2016;36:748-55. [Ref.ID 100894]
13. Cita con resumen
Anónimo. FDA approves drug designed to protect heart patients from aspirin-related stomach ulcers. Drugs.com 2016:16 de septiembre. [Ref.ID 100669]
14. Cita con resumen
Anónimo. Comparative effectiveness of proton pump inhibitors. Therapeutics Initiative Evidence Based Drug Therapy 2016;99:1-2. [Ref.ID 100573]
15. Cita con resumen
Anónimo. Métoclopramide, dompéridone: morts subites, arythmies ventriculaires. Prescrire 2016;36:351-4. [Ref.ID 100540]
16.Tiene citas relacionadas Cita con resumen
Kuller LH. Do proton pump inhibitors increase the risk of dementia?. JAMA Neurology 2016;73:379-81. [Ref.ID 100322]
17.Tiene citas relacionadas Cita con resumen
Gomm W, von Holt K, Thomé F, Broich K, Maier W, Fink A, Doblhammer G, Haenisch B. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurology 2016;73:410-6. [Ref.ID 100299]
18. Cita con resumen
Jones MG, Tsega S, Cho HJ. Inappropriate prescription of proton pump inhibitors in the setting of steroid use: a teachable moment. JAMA Intern Med 2016;176:594-5. [Ref.ID 100256]
19.Enlace a cita original Cita con resumen
Begley J, Smith T, Burnett K, Strike P, Azim A, Spake C, Richardson T. Proton pump inhibitor hypomagnasemia - a cause for concern?. Br J Clin Pharmacol 2016;81:753-8. [Ref.ID 100179]
20. Cita con resumen
Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol 2016:14 de abril. [Ref.ID 100161]
Seleccionar todas
 
 1 a 20 de 620 siguiente >>